Pharmaceuticals company Wockhardt announced Q1FY26 results Revenue for Q1FY26 is Rs 738 crore compared to Rs 747 crore in Q1FY25. EBITDA for Q1FY26 of Rs 101 crore compared to Rs 100 crore in Q1FY25. EBITDA Margin: 13.7% for Q1FY26. PBT: Rs -109 crore compared to Rs -6 crore during Q1FY25. PAT: Rs -108 crore compared to Rs -16 crore during Q1FY25. PAT Margin: -14.6% for Q1FY26. Result PDF